Holen Sie sich die Stockscreener-App
91.01
0.02%
0.026
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$90.98
Offen:
$90.11
24-Stunden-Volumen:
915.93K
Relative Volume:
0.70
Marktkapitalisierung:
$10.56B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
38.73
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
-0.21%
1M Leistung:
+9.81%
6M Leistung:
-6.78%
1J Leistung:
-25.96%
1-Tages-Spanne:
$88.75
$92.16
1-Wochen-Bereich:
$88.06
$92.50
52-Wochen-Spanne:
$81.36
$129.50
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Vergleichen Sie RVTY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
91.02 | 10.56B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
524.91 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.25 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.71 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.11 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.02 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
TD Cowen Adjusts Price Target on Revvity to $120 From $126, Maintains Buy Rating - MarketScreener
Revvity Showcases Progress with Purpose in 2025 Impact Report - Business Wire
Revvity Unveils New AI Software Offering To Transform Preclinical Imaging Analysis - Technology Networks
Applying big data sentiment scoring on Revvity Inc.2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
Will Revvity Inc. rebound enough to break evenTrade Analysis Report & Daily Growth Stock Investment Tips - newser.com
How Revvity Inc. (PKN) stock reacts to Fed tightening2025 Trading Volume Trends & Weekly High Return Stock Opportunities - newser.com
Revvity's Moat Rating Downgraded as Portfolio Transformations Weigh on Economic Returns - Morningstar
Revvity Closes Second Massachusetts Site, Increases Layoffs Amid Operational Consolidation - Boston Real Estate Times
Can Revvity Inc. stock withstand economic slowdownJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Why analysts remain bullish on Revvity Inc. stockBreakout Watch & High Yield Stock Recommendations - newser.com
Leerink Partners Adjusts Revvity Price Target to $120 From $110, Maintains Outperform Rating - MarketScreener
Sivik Global Healthcare LLC Purchases Shares of 45,000 Revvity Inc. $RVTY - MarketBeat
Revvity Inc. $RVTY Shares Bought by Triodos Investment Management BV - MarketBeat
Revvity, Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges - Markets Mojo
Major Mass. biomanufacturer closes 2nd site, lays off more workers - The Business Journals
Medpace and Revvity Stocks Trade Down, What You Need To Know - TradingView
Revvity Inc. stock momentum explained2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Using fundamentals and technicals on Revvity Inc.Market Sentiment Summary & Verified Technical Trade Signals - newser.com
How to track smart money flows in Revvity Inc.IPO Watch & Safe Capital Growth Trade Ideas - newser.com
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes - sharewise.com
Revvity Inc. stock trend outlook and recovery pathFed Meeting & Risk Managed Investment Strategies - newser.com
Will Revvity Inc. see short term momentumJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Best data tools to analyze Revvity Inc. stock2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Is Revvity Inc. stock a top pick for value investorsWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Will Revvity Inc. (PKN) stock enhance shareholder valueWeekly Investment Recap & Stock Timing and Entry Methods - newser.com
Will Revvity Inc. stock sustain high P E ratios2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Chart based analysis of Revvity Inc. trends2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Revvity (RVTY): Evaluating Valuation Potential After Recent Modest Recovery in Share Price - Yahoo Finance
Evercore ISI Group Maintains Revvity (RVTY) Outperform Recommendation - Nasdaq
Evercore ISI Lowers Revvity (NYSE:RVTY) Price Target to $106.00 - MarketBeat
Evercore ISI Adjusts Revvity Price Target to $106 From $108, Maintains Outperform Rating - MarketScreener
Drake & Associates LLC Acquires 12,553 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity to Hold Earnings Call on Monday, October 27, 2025 - PharmiWeb.com
Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout - MedTech Dive
Is Revvity Inc. stock undervalued vs historical averagesBuy Signal & Community Verified Trade Alerts - newser.com
Revvity (RVTY) Is Up 11.9% After Announcing Sanofi Alliance to Expand Diabetes Diagnostics Portfolio - Sahm
What drives Revvity Inc stock priceShort-Term Trading Alerts & These Picks Are Just One Breakout Away - earlytimes.in
Can a trend reversal in Revvity Inc. lead to recoveryChart Signals & Stock Timing and Entry Methods - newser.com
Using AI based signals to follow Revvity Inc.Trade Volume Report & Risk Controlled Daily Trade Plans - newser.com
A Fresh Look at Revvity (RVTY) Valuation After Sanofi Partnership in Early Diabetes Screening - Sahm
Revvity to develop type 1 diabetes early detection assay with Sanofi - Investing.com Nigeria
Automated trading signals detected on Revvity Inc.Trade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Order flow analysis tools used on Revvity Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Lucem, Revvity partner with Sanofi for early T1D detection - BioWorld MedTech
Barclays Adjusts Revvity (RVTY) Price Target, Maintains Overweig - GuruFocus
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):